Author:
Bschleipfer T,Cimniak H-U,Beckert R,Hauck E W,Weidner W,Sparwasser C
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Porst H . The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. J Urol 1996; 155: 802–815.
2. Porst H . Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil—a comparative study in 103 patients with erectile dysfunction. Int J Impot Res 1997; 9: 187–192.
3. Hauck EW et al. Prostaglandin E1 long-term self-injection programme for treatment of erectile dysfunction—a follow-up of at least 5 years. Andrologia 1999; 31(Suppl 1): S99–S103.
4. Linet OI, Ogrinc FG . Penile fibrosis during 18 months of intracavemosal therapy with alprostadil (Caverject™). Int J Impot Res 1996; 8: D85.
5. Porst H et al. Final results of a prospective multicenter-study with self-injection therapy with PGE1 after 4 years of follow-up. Int J Impot Res 1996; 8: D118.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献